Patient LOS is a critical factor in every Emergency Department. The Aerogen Ultra demonstrated a 37 minute reduction in LOS per patient, reducing from a 4.79 hours average LOS to 4.17 hours (compared to a jet nebuliser)
For the full study poster go to [ Ссылка ]
Aerogen is a trusted medical device company that designs and manufactures innovative aerosol drug delivery systems for the respiratory care market.
We are synonymous with the effective treatment of respiratory illness among patient groups of all ages playing a critical role in emergency departments and intensive care units in over 75 countries worldwide.
With a strong commitment to scientific excellence, Aerogen invests heavily in research and development to evolve its pioneering product range and change the future of respiratory patient care.
Our unique palladium vibrating mesh technology, Aerogen Vibronic® is a breakthrough in aerosol drug delivery and is at the heart of all our products.
The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.
